Overcoming Obstacles to Success When Transitioning Into cGMP
When transitioning medicinal products from R&D to current cGMP production with speed and efficiency, researchers are likely to face a number of challenges.
One aspect that can cause the most significant disruption is managing cGMP and cleanroom production compliance. All too often this aspect is poorly understood, resulting in delays and unforeseen expenses.
This webinar highlights how many of the common pitfalls can be avoided with thoughtful consideration of your equipment needs.
Watch this webinar to explore:
- How to choose the correct equipment to ensure an effective contamination prevention strategy
- Critical considerations for effective lab equipment implementation into a cGMP and cleanroom environment
- How to avoid unwanted particulates that may compromise the safety and quality of your advanced therapy product